These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term levodopa/carbidopa intestinal gel in advanced Parkinson's disease. Cáceres-Redondo MT, Carrillo F, Lama MJ, Huertas-Fernández I, Vargas-González L, Carballo M, Mir P. J Neurol; 2014 Mar; 261(3):561-9. PubMed ID: 24477490 [Abstract] [Full Text] [Related]
5. Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry. Buongiorno M, Antonelli F, Cámara A, Puente V, de Fabregues-Nebot O, Hernandez-Vara J, Calopa M, Pascual-Sedano B, Campolongo A, Valldeoriola F, Tolosa E, Kulisevsky J, Martí MJ. Parkinsonism Relat Disord; 2015 Aug; 21(8):871-6. PubMed ID: 26003410 [Abstract] [Full Text] [Related]
6. Impact of Disease Duration in Effectiveness of Treatment with Levodopa-Carbidopa Intestinal Gel and Factors Leading to Discontinuation. Regidor I, Santos-García D, Catalán MIJ, Puente V, Valldeoriola F, Grandas F, Mir P, Parra JC, Arbelo JM. J Parkinsons Dis; 2019 Aug; 9(1):173-182. PubMed ID: 30562907 [Abstract] [Full Text] [Related]
7. Jejunal Infusion of levodopa-carbidopa intestinal gel versus oral administration of levodopa-carbidopa tablets in japanese subjects with advanced Parkinson's disease: pharmacokinetics and pilot efficacy and safety. Othman AA, Chatamra K, Mohamed ME, Dutta S, Benesh J, Yanagawa M, Nagai M. Clin Pharmacokinet; 2015 Sep; 54(9):975-84. PubMed ID: 25875940 [Abstract] [Full Text] [Related]
9. Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease. Fabbri M, Zibetti M, Beccaria L, Merola A, Romagnolo A, Montanaro E, Ferreira JJ, Palermo S, Lopiano L. Eur J Neurol; 2019 Mar; 26(3):490-496. PubMed ID: 30347489 [Abstract] [Full Text] [Related]
10. Dyskinesias in levodopa-carbidopa intestinal gel infusion era: New challenges, new features. Catalán MJ, Escribano PM, Alonso-Frech F. Mov Disord; 2017 Apr; 32(4):624-625. PubMed ID: 28116835 [No Abstract] [Full Text] [Related]
12. Dopamine dysregulation syndrome and punding in levodopa-carbidopa intestinal gel (LCIG) infusion: A serious but preventable complication. Salomone G, Marano M, di Biase L, Melgari JM, Di Lazzaro V. Parkinsonism Relat Disord; 2015 Sep; 21(9):1124-5. PubMed ID: 26242552 [No Abstract] [Full Text] [Related]
17. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation. Elkouzi A, Ramirez-Zamora A, Zeilman P, Barabas M, Eisinger RS, Malaty IA, Okun MS, Almeida L. Ann Clin Transl Neurol; 2019 Oct; 6(10):1989-1995. PubMed ID: 31518070 [Abstract] [Full Text] [Related]
18. Current Practices for Outpatient Initiation of Levodopa-Carbidopa Intestinal Gel for Management of Advanced Parkinson's Disease in the United States. Amjad F, Bhatti D, Davis TL, Oguh O, Pahwa R, Kukreja P, Zamudio J, Metman LV. Adv Ther; 2019 Sep; 36(9):2233-2246. PubMed ID: 31278691 [Abstract] [Full Text] [Related]